The content is available as a PDF (4.4 MB).
. 2020 Mar 10:hvaa080. doi: 10.1093/clinchem/hvaa080
The SARS-CoV-2 Outbreak: Diagnosis, Infection Prevention, and Public Perception
Ping Wang
h1,✉, Neil Anderson
h2, Yang Pan
h3, Leo Poon
h4, Carmen Charlton
h5, Nathan Zelyas
h6, David Persing
h7, Daniel Rhoads
h8, Hilary Babcock
h9
Ping Wang
h1
University of Pennsylvania Heath System, and the Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
Find articles by Ping Wang
Neil Anderson
h2Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO
Find articles by Neil Anderson
Yang Pan
h3Associate Research Professor, Institute for Infectious Disease and Endemic Disease Control, Beijing Center for Disease Control and Prevention. Beijing, China
Find articles by Yang Pan
Leo Poon
h4Professor, School of Public Health, The University of Hong Kong, Hong Kong
Find articles by Leo Poon
Carmen Charlton
h5Clinical Microbiologist, Public Health Laboratory (ProvLab), University of Alberta Hospital, Edmonton, AB
Find articles by Carmen Charlton
Nathan Zelyas
h6Medical Microbiologist, Provincial Laboratory for Public Health (ProvLab). Program Director, Medical Microbiology Residency Program, University of Alberta, Edmonton, AB
Find articles by Nathan Zelyas
David Persing
h7Executive Vice President and Chief Medical and Technology Officer, Cepheid, Sunnyvale, CA
Find articles by David Persing
Daniel Rhoads
h8Director of Microbiology, University Hospitals Cleveland Medical Center, Cleveland, OH
Find articles by Daniel Rhoads
Hilary Babcock
h9Professor of Medicine, Infectious Diseases, Medical Director, BJC Infection Prevention and Epidemiology Consortium, Washington University School of Medicine, Saint Louis, MO
Find articles by Hilary Babcock
h1
University of Pennsylvania Heath System, and the Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
h2Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO
h3Associate Research Professor, Institute for Infectious Disease and Endemic Disease Control, Beijing Center for Disease Control and Prevention. Beijing, China
h4Professor, School of Public Health, The University of Hong Kong, Hong Kong
h5Clinical Microbiologist, Public Health Laboratory (ProvLab), University of Alberta Hospital, Edmonton, AB
h6Medical Microbiologist, Provincial Laboratory for Public Health (ProvLab). Program Director, Medical Microbiology Residency Program, University of Alberta, Edmonton, AB
h7Executive Vice President and Chief Medical and Technology Officer, Cepheid, Sunnyvale, CA
h8Director of Microbiology, University Hospitals Cleveland Medical Center, Cleveland, OH
h9Professor of Medicine, Infectious Diseases, Medical Director, BJC Infection Prevention and Epidemiology Consortium, Washington University School of Medicine, Saint Louis, MO
✉
Corresponding Author: Ping Wang, Email: ping.wang2@pennmedicine.upenn.edu
Received 2020 Mar 2; Revised 2020 Mar 2; Accepted 2020 Mar 4.
© American Association for Clinical Chemistry 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
PMCID: PMC7108508 PMID: 32154877